National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Defatted powder of Arachis hypogaea L., semen (peanuts) (Palforzia®). HTA ID: 22019

Palforzia® is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. Palforzia® may be continued in patients 18 years of age and older. Palforzia® should be used in conjunction with a peanut-avoidant diet.

 

NCPE Assessment Process Complete
Rapid review commissioned 01/04/2022
Rapid review completed 04/05/2022
Rapid Review outcome A full HTA is recommended to assess the clinical effectiveness and cost effectiveness of Palforzia® compared with the current standard of care.